Table 3.
Vitamin and micronutrient supplementation in our cohort (n = 130).
| Recommended substitution | Substituted patients | Dosage | Prescription according to the recommendationsa |
|
|---|---|---|---|---|
| Vitamin A (U/d) | To be adapted according to biological standards | 126 (97%) | 1,667 [1,250; 11,558] | – |
| Vitamin E (U/d) | 100 à 400 UI/d | 101 (78%) | 329 [291; 736] | 79 (78%) |
| Vitamin D (U/d) | 800 UI/d (up to 2,000 UI/d) | 129 (99%) | 1,441 [870; 3,480] | 99 (77%) |
| Vitamin K (mg/month) | 1 to 10 mg/d | 93 (72%) | 40 [10; 40] | 81 (87%) |
| Selenium (µg/d) | To be adapted according to biological standards | 82 (63%) | 100 [100; 100] | – |
| Zinc (mg/d) | 15 mg/d | 101 (78%) | 5 [5; 6.25] | 17 (17%) |
Data are expressed as n (%) or median [IQR].
a
The recommended values are taken from the ESPEN-ESPGHAN-ECFS dietary recommendations published in 2016. These recommendations have been adapted for patients with exocrine pancreatic insufficiency. It should be noted that there is currently no specific recommendation for selenium replacement. Zinc supplementation is not systematic, but is recommended for those at risk of deficiency, particularly in the presence of delayed puberty or growth or anorexia.